Promising gene therapy delivers treatment directly to brain Scientists say delivering gene therapy directly to the brain holds great promise The Independent UK · Jan 24, 2023
PTC Therapeutics's Return On Capital Employed Overview According to data from Benzinga Pro, during Q1, PTC Therapeutics's (NASDAQ:PTCT) reported sales totaled $148.74 million. Despite a 11.54% increase in earnings, the company posted a loss of $126.73 million. Benzinga · May 12, 2022